Environmental contaminants in pathogenesis of breast cancer

Indian Journal of Experimental Biology

Volumn 44, Issue 8, 2006, Pages 597-617

  Mukherjee, Shyamali ^a   Koner, Bidhan Chandra ^b   Ray, Sanhita ^c   Ray, Amitabha ^d  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aryl hydrocarbon receptor; Breast cancer; Immunotoxicant; Oxidative metabolism; Xenoestrogens

Indexed keywords

CYTOCHROME P450; ESTROGEN; PESTICIDE; XENOBIOTIC AGENT;

ANIMAL; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY; REVIEW; SMOKING;

ANIMALS; BREAST NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; ESTROGENS; HUMANS; PESTICIDES; SMOKING; XENOBIOTICS;

NICOTIANA TABACUM;

EID: 33845691209     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (207)

1. Dumitrescu R G & Cotarla I, Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med, 9 (2005) 208.
2. Report of the National Cancer Registry Programme (Indian Council of Medical Research, New Delhi) 2001.
3. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar A V, Parkin D M & Siddiqi M, Cancer patterns in eastern India: The first report of the Kolkata Cancer Registry, Int J Cancer, 100 (2002) 86.
4. Jussaawala D J, Yeole B B & Natekar M V, Histological and epidemiological features of breast cancer in different religious groups in greater Bombay, J Surg Oncol, 18 (1981) 269.
5. Badwe R A, Gangawal S, Mittra I & Desai P B. Clinicopathological features and prognosis of breast cancer in different religious communities in India, Indian J Cancer, 27 (1990) 220.
6. Yeole B B & Kurkure A P, An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades, Asian Pac J Cancer Prev, 4 (2003) 51.
7. Paymaster T C & Gangadharan P, Cancer in Parsi community of Bombay, Int J Cancer, 5 (1970) 426.
8. Kliewer E V & Smith K R, Breast cancer mortality among immigrants in Australia and Canada, J Natl Cancer Inst, 87 (1995) 1154.
9. Winter H, Cheng K K, Cummins C, Maric R, Silcocks P & Varghese C, Cancer incidence in the south Asian population of England (1990-92), Br J Cancer, 79 (1999) 645.
10. Kotsopoulos J, Liede A, De Matsuda M L, Sun P & Narod S A, Method of cooking and risk of breast cancer in the Philippines, Cancer Causes Control, 17 (2006) 341.
11. Sharma B K, Ray A, Kaur S & Gupta S, Immunohistochemical co-expression of c-erbB-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast, Indian J Exp Biol, 37 (1999) 223.
12. Kuhl H, Breast cancer risk in the WHI study: the problem of obesity, Maturitas, 51 (2005) 83.
13. Onland-Moret N C, Peeters P H, van der Schouw Y T, Grobbee D E & van Gils C H, Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study, J Clin Endocrinol Metab, 90 (2005) 1414.
14. Russo J & Russo I H, Genotoxicity of steroidal estrogens, Trends Endocrinol Metab, 15 (2004) 211.
15. Castagnetta L A, Granata O M, Arcuri F P, Polito L M, Rosati F & Cartoni G P, Gas chromatography/mass spectrometry of catechol estrogens, Steroids, 57 (1992) 437.
16. Liehr J G, Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev, 21 (2000) 40.
17. Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M & Persson I, Cytochrome P4501B1 gene polymorphisms and postmenopausal breast cancer risk, Carcinogenesis, 24 (2003) 1533.
18. Yager J D & Liehr J G, Molecular mechanisms of estrogen carcinogenesis, Annu Rev Pharmacol Toxicol, 36 (1996) 203.
19. Jefcoate C R, Liehr J G, Santen R J, Sutter T R, Yager J D, Yue W, Santner S J, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G & Berstein L, Tissue-specific synthesis and oxidative metabolism of estrogens, J Natl Cancer Inst Monogr, 27 (2000) 95.
20. Mitrunen K & Hirvonen A, Molecular epidemiology of sporadic breast cancer: The role of polymorphic genes involved in oestrogen biosynthesis and metabolism, Mutat Res, 544 (2003) 9.
21. Dawling S, Hachey D L, Roodi N & Parl F F, In vitro model of mammary estrogen metabolism: Structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol, Chem Res Toxicol, 17 (2004) 1258.
22. Emerit I, Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis, Free Radic Biol Med, 16 (1994) 99.
23. Vaca C E, Wilhelm J & Harms-Ringdal M, Interaction of lipid peroxidation products with DNA. A review, Mutat Res, 195 (1988) 137.
24. Kumaraguruparan R, Kabalimoorthy J & Nagini S, Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast, Clin Biochem, 38 (2005) 154.
25. Phillips D H, Martin F L, Williams J A, Wheat L M, Nolan L, Cole K J & Grover P L, Mutagens in human breast lipid and milk: the search for environmental agents that initiate breast cancer, Environ Mol Mutagen, 39 (2002) 143.
26. Li D, Wang M, Firozi P F, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri S V, Goth-Goldstein R, Weyand E H & DiGiovanni J, Characterization of a major aromatic DNA adduct detected in human breast tissues, Environ Mol Mutagen, 39 (2002) 193.
27. Wang M, Dhingra K, Hittelman W N, Liehr J G, de Andrade M & Li D, Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues, Cancer Epidemiol Biomarkers Prev, 5 (1996) 705.
28. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, Watanabe M, Hibi T & Kitajima M, Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes, Cancer Lett, 151 (2000) 87.
29. Williams J A & Phillips D H, Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer, Cancer Res, 60 (2000) 4667.
30. Oyama T, Morita M, Isse T, Kagawa N, Nakata S, So T, Mizukami M, Ichiki Y, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kawamoto T & Yasumoto K, Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer, Front Biosci, 10 (2005) 1156.
31. Modugno F, Knoll C, Kanbour-Shakir A & Romkes M, A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis, Breast Cancer Res Treat, 82 (2003) 191.
32. El-Rayes B F, Ali S, Heilbrun L K, Lababidi S, Bouwman D, Visscher D & Philip P A, Cytochrome P450 and glutathione transferase expression in human breast cancer, Clin Cancer Res, 9 (2003) 1705.
33. Tas F, Hansel H, Belce A, Ilvan S, Argon A, Camlica H & Topuz E, Oxidative stress in breast cancer, Med Oncol, 22 (2005) 11.
34. Portakal O, Ozkaya O, Inal M E, Bozan B, Kosan M & Sayek I, Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients, Clin Biochem, 33 (2000) 279.
35. Er T K, Hou M F, Tsa E M, Lee J N & Tsai L Y, Differential expression of manganese containing superoxide dismutase in patients with breast cancer in Taiwan, Ann Clin Lab Sci, 34 (2004) 159.
36. Thomas P A, Oykutlu D, Pou B, Tyler D, Oberley L W, Robinson R A & Lenel J C, Immunohistochemical characterization of antioxidant enzymes in human breast cancer, Pathol Oncol Res, 3 (1997) 278.
37. Cai Q, Shu X O, Wen W, Cheng J R, Dai Q, Gao Y T & Zheng W, Genetic polymorphism in the manganese Superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study, Breast Cancer Res, 6 (2004) R647.
38. Williams J A, Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression, Carcinogenesis, 22 (2001) 209.
39. Lin S C, Chou Y C, Wu M H, Wu C C, Lin W Y, Yu C P, Yu J C, You S L, Chen C J & Sun C A, Genetic variants of myeloperoxidase and catechol-O- methyltransferase and breast cancer risk, Eur J Cancer Prev, 14 (2005) 257.
40. Bekesi G, Kakucs R, Varbiro S, Feher J, Pazmany T, Magyar Z, Sprintz D & Szekacs B, Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy, BJOG, 108 (2001) 474.
41. Nowell S A, Ahn J & Ambrosone C B, Gene-nutrient interactions in cancer etiology, Nutr Rev, 62 (2004) 427.
42. Mannisto P T, Ulmanen I, Lundstrom K, Taskinen J, Tenhunen J, Tilgmann C & Kaakkola S, Characteristics of catechol-O-methyl-transferase (COMT) and properties of selective COMT inhibitors, Prog Drug Res, 39 (1992) 291.
43. Whalen R & Boyer T D, Human glutathione S-transferases, Semin Liver Dis, 18 (1998) 345.
44. Salinas A E & Wong M G, Glutathion S-transferases - a review, Curr Med Chem, 6 (1999) 279.
45. Sheweita S A & Tilmisany A K, Cancer and phase II drug-metabolizing enzymes, Curr Drug Metab, 4 (2003) 45.
46. Forrester L M, Hayes J D, Millis R, Barnes D, Harris A L, Schlager J J, Powis G & Wolf C R, Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue, Carcinogenesis, 11 (1990) 2163.
47. Suzuki T, Miki Y, Nakata T, Shiotsu Y, Akinaga S, Inoue K, Ishida T, Kimura M, Moriya T & Sasano H, Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma, J Steroid Biochem Mol Biol, 86 (2003) 449.
48. Yoshimura N, Harada N, Bukholm I, Karesen R, Borresen-Dale A L & Kristensen V N, Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer, Breast Cancer Res, 6 (2004) R46.
49. Aust S, Obrist P, Klimpfinger M, Tucek G, Jager W & Thalhammer T, Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue, Int J Oncol, 26 (2005) 1079.
50. Williams J A, Stone E M, Fakis G, Johnson N, Meinl W, Glatt H, Sim E & Phillips D H, Human mammary NAT and SULT enzymes metabolically activate N-hydroxylated heterocyclic amines, but NAT enzyme activity is not influenced by NAT genotype, Proc Am Assoc Cancer Res, 41 (2000) 551.
51. Mukherjee S, Nayyar T, Chytil F & Das S K, Mainstream and sidestream cigarette smoke exposure increases retinol in guinea pig lungs, Free Radic Biol Med, 18 (1995) 507.
52. Mukundan H, Bahadur A K, Kumar A, Sardana S, Naik SLD, Ray A & Sharma B K, Glutathione level and its relation to radiation therapy in patients with cancer of uterine cervix, Indian J Exp Biol, 37 (1999) 859.
53. Russo I H, Cigarette smoking and risk of breast cancer in women, Lancet, 360 (2002) 1033.
54. Terry P D, Miller A B & Rohan T E, Cigarette smoking and breast cancer risk: a long latency period? Int J Cancer, 100 (2002) 723.
55. Couch F J, Cerhan J R, Vierkant R A, Grabrick D M, Therneau T M, Pankratz V S, Hartmann L C, Olson J E, Vachon C M & Sellers T A, Cigarette smoking increases risk for breast cancer in high-risk breast cancer families, Cancer Epidemiol Biomarkers Prev, 10 (2001) 327.
56. Innes K E & Byers T E, Smoking during pregnancy and breast cancer risk in very young women (United States), Cancer Causes Control, 12 (2001) 179.
57. Murin S & Inciardi J, Cigarette smoking and the risk of pulmonary metastasis from breast cancer, Chest, 119 (2001) 1635.
58. Baron J A, Newcomb P A, Longnecker M P, Mittendorf R, Storer B E, Clapp R VV, Bogdan G & Yuen J, Cigarette smoking and breast cancer, Cancer Epidemiol Biomarkers Prev, 5 (1996) 399.
59. Terry P D & Rohan T E, Cigarette smoking and the risk of breast cancer in women: a review of the literature, Cancer Epidemiol Biomarkers Prev, 11 (2002) 953.
60. Lash T L & Aschengrau A, A null association between active or passive cigarette smoking and breast cancer risk, Breast Cancer Res Treat, 75 (2002) 181.
61. Ambrosone C B & Shields P, Smoking as a risk factor for breast cancer, in Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics, edited by A. Bowcock (Humana Press, Totowa, NJ) 2001, 519.
62. Hecht S S, Tobacco smoke carcinogens and breast cancer, Environ Mol Mutagen, 39 (2002) 119.
63. Pryor W A, Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity, Environ Health Perspect, 105 (Suppl. 4) (1997) 875.
64. Morabia A, Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001, Environ Mol Mutagen, 39 (2002) 89.
65. Wartenberg D, Calle E E, Thun M J, Heath C W Jr, Lally C & Woodruff T, Passive smoking exposure and female breast cancer mortality, J Natl Cancer Inst, 92 (2000) 1666.
66. Liu L, Wu K, Lin X, Yin W, Zheng X, Tang X, Mu L, Hu Z & Wang J, Passive smoking and other factors at different periods of life and breast cancer risk in Chinese women who have never smoked - a case-control study in Chongqing, People's Republic of China, Asian Pac J Cancer Prev, 1 (2000) 131.
67. Shrubsole M J, Gao Y T, Dai Q, Shu XO, Ruan Z X, Jin F & Zheng W, Passive smoking and breast cancer risk among non-smoking Chinese women, Int J Cancer, 110 (2004) 605.
68. Hanaoka T, Yamamoto S, Sobue T, Sasaki S, Tsugane S & Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Disease Study Group, Active and passive smoking and breast cancer risk in middle-aged Japanese women, Int J Cancer, 114 (2005) 317.
69. Ambrosone C B, Freudenheim J L, Graham S, Marshall J R, Vena J E, Brasure J R, Michalek A M, Laughlin R, Nemoto T, Gillenwater K A & Shields P G, Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk, JAMA, 276 (1996) 1494.
70. Chang-Claude J, Kropp S, Jager B, Bartsch H & Risch A, Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk, Cancer Epidemiol Biomarkers Prev, 11 (2002) 698.
71. van der Hel O L, Peeters P H M, Hein D W, Doll M A, Grobbee D E, Kromhout D & de Mesquita H B B, NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women, Pharmacogenetics, 13 (2003) 399.
72. Coyle Y M, The effect of environment on breast cancer risk, Breast Cancer Res Treat, 84 (2004) 273.
73. Rennix C P, Quinn M M, Amoroso P J, Eisen E A & Wegman D H, Risk of breast cancer among enlisted army women occupationally exposed to volatile organic compounds, Am J Ind Med, 48 (2005) 157.
74. Takkouche B, Etminan M & Montes-Martinez A, Personal use of hair dyes and risk of cancer: a meta-analysis, JAMA, 293 (2005) 2516.
75. Velicer C M, Heckbert S R, Rutter C, Lampe J W & Malone K, Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States), Cancer Causes Control, 17 (2006) 307.
76. Ray A, Ray S & Koner B C, Hypertension, cancer and angiogenesis: Relevant epidemiological and pharmacological aspects, Indian J Pharmacol, 36 (2004) 341.
77. Colborn T, Dumanoski D & Myers J P, Our Stolen Future (Penguin, New York) 1996.
78. th National Conference of the Association of Medical Biochemists of India (New Delhi) 2000, 57.
79. Witorsch R J, Endocrine disrupters: can biological effects and environment risk be predicted? Regul Toxicol Pharmacol, 36 (2002) 118.
80. Safe S, Endocrine disruptors and human health - is there a problem? An update, Environ Health Perspect, 108 (2000) 487.
81. Recchia A G, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, Bonofiglio D & Maggiolini M, Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha, Food Addit Contam, 21 (2004) 134.
82. Harvey P W & Everett D J, Regulation of endocrine-disrupting chemicals: Critical overview and deficiencies in toxicology and risk assessment for human health, Best Pract Res Clin Endocrinol Metab, 20 (2006) 145.
83. Kortenkamp A, Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective, Int J Androl, 29 (2006) 193.
84. Kaminuma T, Takai-Igarashi T, Nakano T & Nakata K, Modeling of signaling pathways for endocrine disruptors, BioSystems, 55 (2000) 23.
85. Safe S & McDougal A, Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review), Int J Oncol, 20 (2002) 1123.
86. Figa-Talamanca I, Mearelli I, Valente P & Bascherini S, Cancer mortality in a cohort of rural licensed pesticide users in the province of Rome, Int J Epidemiol, 22 (1993) 579.
87. Wesseling G, Antich D, Hogstedt C, Rodriguez A C & Ahlbom A, Geographical differences of cancer incidence in Costa Rica in relation to environmental and occupational pesticide exposure, Int J Epidemiol, 28 (1999) 365.
88. Koner B C, Banerjee B D & Ray A, Organochlorine pesticide-induced oxidative stress and immune suppression in rats, Indian J Exp Biol, 36 (1998) 395.
89. Ray S, Studies on paraquat toxicity in rat, Ph.D. thesis, University of Calcutta, Kolkata, 2001.
90. Iscan M, Coban T, Cok I, Bulbul D, Eke B C & Burgaz S, The organochlorine pesticide residues and antioxidant enzyme activities in human breast tumors: is there any association? Breast Cancer Res Treat, 72 (2002) 173.
91. Banerjee B D, Koner B C & Ray A, Immunotoxicity of pesticides: perspectives and trends, Indian J Exp Biol, 34 (1996) 723.
92. Burow M E, Tang Y, Collins-Burow B M, Krajewski S, Reed J C, McLachlan J A & Beckman B S, Effects of environmental estrogens on tumor necrosis factor α-mediated apoptosis in MCF-7 cells, Carcinogenesis, 20 (1999) 2057.
93. Ray A & Mitra A B, Estrogen and breast cancer, ICMR Bull, 33 (2003) 13.
94. Starek A, Estrogens and organochlorine xenoestrogens and breast cancer risk, Int J Occup Med Environ Health, 16 (2003) 113.
95. Schecter A, Toniolo P, Dai L C, Thuy L T & Wolff M S, Blood levels of DDT and breast cancer risk among women living in the north of Vietnam, Arch Environ Contam Toxicol, 33 (1997) 453.
96. Wolff M S, Berkowitz G S, Brower S, Senie R, Bleiweiss I J, Tartter P, Pace B, Roy N, Wallenstein S & Weston A, Organochlorine exposures and breast cancer risk in New York city women, Environ Res, 84 (2000) 151.
97. Lopez-Cervantes M, Torres-Sanchez L, Tobias A & Lopez-Carrillo L, Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiological evidence, Environ Health Perspect, 112 (2004) 207.
98. Raaschou-Nielsen O, Pavuk M, Leblanc A, Dumas P, Philippe Weber J, Olsen A, Tjonneland A, Overvad K & Olsen J H, Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women, Cancer Epidemiol Biomarkers Prev, 14 (2005) 67.
99. Aronson K J, Miller A B, Woolcott C G, Sterns E E, McCready D R, Lickley L A, Fish E B, Hiraki G Y, Holloway C, Ross T, Hanna W M, Sengupta S K & Weber J P, Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk, Cancer Epidemiol Biomarkers Prev, 9 (2000) 55.
100. Stellman S D, Djordjevic M V, Britton J A, Muscat J E, Citron M L, Kemeny M, Busch E & Gong L, Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York, Cancer Epidemiol Biomarkers Prev, 9 (2000) 1241.
101. Woolcott C G, Aronson K J, Hanna W M, Sengupta S K, McCready D R, Sterns E E & Miller A B, Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada), Cancer Causes Control, 12 (2001) 395.
102. Hoyer A P, Gerdes A M, Jorgensen T, Rank F & Hartvig H B, Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study, Breast Cancer Res Treat, 71 (2002) 59.
103. Mathur V, Bhatnagar P, Sharma R G, Acharya V & Saxena R, Breast cancer incidence and exposure to pesticides among women originating from Jaipur, Environ Int, 28 (2002) 331.
104. Charlier C, Albert A, Herman P, Hamoir E, Gaspard U, Meurisse M & Plomteux G, Breast cancer and serum organochlorine residues, Occup Environ Med, 60 (2003) 348.
105. Pavuk M, Cerhan J R, Lynch C F, Kocan A, Petrik J & Chovancova J, Case-control study of PCBs, other Organochlorines and breast cancer in eastern Slovakia, J Expo Anal Environ Epidemiol, 13 (2003) 267.
106. Muscat J E, Britton J A, Djordjevic M V, Citron M L, Kemeny M, Busch-Devereaux E, Pittman B & Stellman S D, Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York, Cancer Epidemiol Biomarkers Prev, 12 (2003) 1474.
107. Ibarluzea J M, Fernandez M F, Santa-Marina L, Olea-Serrano M F, Rivas A M, Aurrekoetxea J J, Exposito J, Lorenzo M, Tome P, Villalobos M, Pedraza V, Sasco A J & Olea N, Breast cancer risk and the combined effect of environmental estrogens, Cancer Causes Control, 15 (2004) 591.
108. Mills P K & Yang R, Breast cancer risk in Hispanic agricultural workers in California, Int J Occup Environ Health, 11 (2005) 123.
109. Cassidy R A, Natarajan S & Vaughan G M, The link between the insecticide heptachlor epoxide, estradiol, and breast cancer, Breast Cancer Res Treat, 90 (2005) 55.
110. Snedeker S M, Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin, Environ Health Perspect, 109 (Suppl 1) (2001) 35.
111. Ejaz S, Akram W, Lim C W, Lee J J & Hussain I, Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan, Exp Oncol, 26 (2004) 98.
112. Calle E E, Frumkin H, Henley S J, Savitz D A & Thun M J, Organochlorines and breast cancer risk, CA Cancer J Clin, 52 (2002) 301.
113. Mitra A K, Faruque F S & Avis A L, Breast cancer and environmental risks: where is the link? J Environ Health, 66 (2004) 24.
114. Moorman P G & Terry P D, Consumption of dairy products and the risk of breast cancer: a review of the literature, Am J Clin Nutr, 80 (2004) 5.
115. Coyle Y M, Hynan L S, Euhus D M & Minhajuddin A T M, An ecological study of the association of environmental chemicals on breast cancer incidence in Texas, Breast Cancer Res Treat, 92 (2005) 107.
116. Minervini F, Giannoccaro A, Cavallini A & Visconti A, Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters, Toxicol Lett, 159 (2005) 272.
117. Ahamed S, Foster J S, Bukovsky A & Wimalasena J, Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells, Mol Carcinog, 30 (2001) 88.
118. Goldman R & Shields P G, Food mutagens. J Nutr, 133 (2003) 965S.
119. Tritscher A M, Human health risk assessment of processing-related compounds in food, Toxicol Lett, 149 (2004) 177.
120. Crews C, Brereton P & Davies A, The effects of domestic cooking on the levels of 3-monochloropropanediol in foods, Food Addit Contam, 18 (2001) 271.
121. Jagerstad M & Skog K, Genotoxicity of heat-processed foods. Mutat Res, 574 (2005) 156.
122. Blank I, Current status of acrylamide research in food: measurement, safety assessment, and formation, Ann NY Acad Sci, 1043 (2005) 30.
123. Rice J M, The carcinogenicity of acrylamide, Mutat Res, 580 (2005) 3.
124. Erdreich L S & Friedman M A, Epidemiologic evidence for assessing the carcinogenicity of acrylamide, Regul Toxicol Pharmacol, 39 (2004) 150.
125. Fiddler W, The occurrence and determination of N-nitroso compounds, Toxicol Appl Pharmacol, 31 (1975) 352.
126. Wogan G N & Tannenbaum S R, Environmental N-nitroso compounds: implications for public health, Toxicol Appl Pharmacol, 31 (1975) 375.
127. Bartsch H & Montesano R, Relevance of nitrosamines in human cancer, Carcinogenesis, 5 (1984) 1381.
128. Ahn H J, Jo C, Kim J H, Chung Y J, Lee C H & Byun M W, Monitoring of nitrite and N-nitrosamine levels in irradiated pork sausage, J Food Prot, 65 (2002) 1493.
129. Lin K, Shen Z Y, Lu S H & Wu Y N, Intake of volatile N-nitrosamines and their ability to exogenously synthesize in the diet of inhabitants from high-risk area of esophageal cancer in southern China, Biomed Environ Sci, 15 (2002) 277.
130. Lee S J, Shin J H, Sung N J, Kim J G & Hotchkiss J H, Effect of cooking on the formation of N-nitrosodimethylamine in Korean dried seafood products, Food Addit Contam, 20 (2003) 31.
131. Lijinsky W, In vivo testing for carcinogenicity, in Chemical Carcinogenesis and Mutagenesis I, edited by C S Cooper & P L Grover (Springer-Verlag, Berlin, Germany) 1990, 179.
132. Wogan G N, Hecht S S, Felton J S, Conney A H & Loeb L A, Environmental and chemical carcinogenesis, Semin Cancer Biol, 14 (2004) 473.
133. Gammon D W, Aldous C N, Carr W C Jr, Sanborn J R & Pfeifer K F, A risk assessment of atrazine use in California: human health and ecological aspects, Pest Manag Sci, 61 (2005) 331.
134. Meador J P, Stein J E, Reichert W L & Varanasi U, Bioaccumulation of polycyclic aromatic hydrocarbons by marine organisms, Rev Environ Contam Toxicol, 143 (1995) 79.
135. Guillen M D, Sopelana P & Partearroyo M A, Food as a source of polycyclic aromatic carcinogens, Rev Environ Health, 12 (1997) 133.
136. Phillips D H, Polycyclic aromatic hydrocarbons in the diet. Mutat Res, 443 (1999) 139.
137. Brody J G & Rudel R A, Environmental pollutants and breast cancer, Environ Health Perspect, 111 (2003) 1007.
138. Autrup H, Harris C C, Trump B F & Jeffrey A H, Metabolism of benzo(a)pyrene and identification of the major benzo(a)pyrene-DNA adducts in cultured human colon, Cancer Res, 38 (1978) 3689.
139. BeBruin L S & Josephy P D, Perspectives on the chemical etiology of breast cancer, Environ Health Perspect, 110 (Suppl 1) (2002) 119.
140. Murkovic M, Formation of heterocyclic aromatic amines in model systems, J Chromatogr B, 802 (2004) 3.
141. Weisburger J H, Antimutagens, anticarcinogens, and effective worldwide cancer prevention, J Environ Pathol Toxicol Oncol, 18 (1999) 85.
142. Ferguson L R, Meat consumption, cancer risk and population groups within New Zealand, Mutat Res, 506-507 (2002) 215.
143. De Stefani E, Ronco A, Mendilaharsu M, Guidobono M & Deneo-Pellegrini H, Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay, Cancer Epidemiol Biomarkers Prev, 6 (1997) 573.
144. Knize M G & Felton J S, Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat, Nutr Rev, 63 (2005) 158.
145. Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 56 (International Agency for Research on Cancer, Lyon, France) 1993, 163.
146. Kawanishi M, Sakamoto M, Ito A, Kishi K & Yagi T, Construction of reporter yeasts for mouse aryl hydrocarbon receptor ligand activity, Mutat Res, 540 (2003) 99.
147. Mandal P K, Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology, J Comp Physiol B, 175 (2005) 221.
148. Warner M, Eskenazi B, Mocarelli P, Gerthoux P M, Samuels S, Needham L, Patterson D & Brambilla P, Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study, Environ Health Perspect, 110 (2002) 625.
149. Landi M T, Bertazzi P A, Baccarelli A, Consonni D, Masten S, Lucier G, Mocarelli P, Needham L, Caporaso N & Grassman J, TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident, Carcinogenesis, 24 (2003) 673.
150. Baccarelli A, Pesatori A C, Masten S A, Patterson D G Jr, Needham L L, Mocarelli P, Caporaso N E, Consonni D, Grassman J A, Bertazzi P A & Landi M T, Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy, Toxicol Lett, 149 (2004) 287.
151. Flesch-Janys D, Becher H, Manz A, Morgenstern I, Nagel S, Steindorf K, Epidemiological investigation of breast cancer incidence in a cohort of female workers with high exposure to PCDD/F and HCH, Organohalogen Compounds, 44 (1999) 379.
152. Manz A, Berger J, Dwyer J H, Flesch-Janys D, Nagel S, Waltsgott H, Cancer mortality among workers in chemical plant contaminated with dioxin, Lancet, 338 (1991) 959.
153. Kogevinas M, Becher H, Benn T, Bertazzi P A, Boffetta P, Bueno-de-Mesquita H B, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews J D, Neuberger M, Pearce N & Saracci R, Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study, Am J Epidemiol, 145 (1997) 1061.
154. Revich B, Aksel E, Ushakova T, Ivanova I, Zhuchenko N, Klyuev N, Brodsky B & Sotskov Y, Dioxin exposure and public health in Chapaevsk, Russia, Chemosphere, 43 (2001) 951.
155. Brown N M, Manzolillo P A, Zhang J X, Wang J & Lamartiniere C A, Prenatal TCDD and predisposition to mammary cancer in the rat, Carcinogenesis, 19 (1998) 1623.
156. Demers A, Ayotte P, Brisson J, Dodin S, Robert J & Dewailly E, Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis, Am J Epidemiol, 155 (2002) 629.
157. Wassermann M, Nogueira D P, Tomatis L, Mirra A, Shibata H, Arie G, Cucos S & Wassermann D, Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue, Bull Environ Contam Toxicol, 15 (1976) 478.
158. Falck F Jr, Ricci A, Wolff M S, Godbold J & Deckers P, Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer, Arch Environ Health, 47 (1992) 143.
159. Liljegren G, Hardell L, Lindstrom G, Dahl P & Magnuson A, Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene, Eur J Cancer Prev, 7 (1998) 135.
160. Guttes S, Failing K, Neumann K, Kleinstein J, Georgii S & Brunn H, Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease, Arch Environ Contam Toxicol, 35 (1998) 140.
161. Lucena R A, Allam M F, Costabeber I H, Villarejo M L & Navajas R F, Breast cancer risk factors: PCB congeners, Eur J Cancer Prev, 10 (2001) 117.
162. Zhang Y, Wise J P, Holford T R, Xie H, Boyle P, Zahm S H, Rusiecki J, Zou K, Zhang B, Zhu Y, Owens P H & Zheng T, Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women, Am J Epidemiol, 160 (2004) 1177.
163. Li Y, Millikan R C, Bell D A, Cui L, Tse C K, Newman B & Convvay K, Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study, Breast Cancer Res, 7 (2005) R12.
164. Petralia S A, Vena J E, Freudenheim J L, Dosemeci M, Michalek A, Goldberg M S, Brasure J & Graham S, Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene, Scand J Work Environ Health, 25 (1999) 215.
165. Bonner M R, Han D, Nie J, Rogerson P, Vena J E, Muti P, Trevisan M, Edge S B & Freudenheim J L, Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure, Cancer Epidemiol Biomarkers Prev, 14 (2005) 53.
166. Khorram O, Garthwaite M & Golo S, Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions, Mol Hum Reprod, 8 (2002) 75.
167. Wong J M, Harper P A, Meyer U A, Bock K W, Morike K, Lagueux J, Ayotte P, Tyndale R F, Sellers E M, Manchester D K & Okey A B, Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro, Pharmacogenetics, 11 (2001) 85.
168. Dialyna I A, Arvanitis D A & Spandidos D A, Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer, Int J Mol Med, 8 (2001) 79.
169. Angus W G, Larsen M C & Jefcoate C R, Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status, Carcinogenesis, 20 (1999) 947.
170. Trombino A F, Near R I, Matulka R A, Yang S, Hafer L J, Toselli P A, Kim D W, Rogers A E, Sonenshein G E & Sherr D H, Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis, Breast Cancer Res Treat, 63 (2000) 117.
171. Lin P, Chang J T, Ko J L, Liao S H & Lo W S, Reduction of androgen receptor expression by benzo[alpha]pyrene and 7,8-dihydro-9,10-epoxy-7,8,9,10- tetrahydrobenzo[alpha]pyrene in human lung cells, Biochem Pharmacol, 67 (2004) 1523.
172. Uno S, Dalton T P, Shertzer H G, Genter M B, Warshawsky D, Talaska G & Nebert D W, Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels, Biochem Biophys Res Commun, 289 (2001) 1049.
173. Russo J, Tahin Q, Lareef M H, Hu Y F & Russo I H, Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens, Environ Mol Mutagen, 39 (2002) 254.
174. Spink D C, Katz B H, Hussain M M, Pentecost B T, Cao Z & Spink B C, Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells, Carcinogenesis, 24 (2003) 1941.
175. Matsumura F, On the significance of the role of cellular stress response reactions in the toxic actions of dioxin, Biochem Pharmacol, 66 (2003) 527.
176. Angus W G, Larsen M C & Jefcoate C R, TCDD elevates erbB2 expression and signaling in T47D cells by reversing serum potentiation of estrogen receptor activity, independent of estrogen levels and enhanced ER down-regulation, Mol Cell Endocrinol, 170 (2000) 1.
177. + T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD, Toxicol Appl Pharmacol, 185 (2002) 146.
178. Doi H, Baba T, Tohyama C & Nohara K, Functional activation of aryl hydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p- dioxin, Chemosphere, 52 (2003) 655.
179. Laupeze B, Amiot L, Sparfel L, Ferrec E L, Fauchet R & Fardel O, Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells, J Immunol, 168 (2002) 2652.
180. Coumailleau P, Poellinger L, Gustafsson J A & Whitelaw M L, Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity, J Biol Chem, 270 (1995) 25291.
181. Pocar P, Fischer B, Klonisch T & Klonisch-Hombach S, Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction, Reproduction, 129 (2005) 379.
182. Fukuda I, Sakane I, Yabushita Y, Kodol R, Nishiumi S, Kakuda T, Sawamura S, Kanazawa K & Ashida H, Pigments in green tea leaves (Camellia sinensis) suppress transformation of the aryl hydrocarbon receptor induced by dioxin, J Agric Food Chem, 52 (2004) 2499.
183. Gonzalez F J & Fernandez-Salguero P, The aryl hydrocarbon receptor: studies using the AHR-null mice, Drug Metab Dispos, 26 (1998) 1194.
184. Schmidt J V & Bradfield C A, Ah receptor signaling pathways, Annu Rev Cell Dev Biol, 12 (1996) 55.
185. Kohle C, Hassepass I, Bock-Hennig B S, Bock K W, Poellinger L & McGuire J, Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells, Arch Biochem Biophys, 402 (2002) 172.
186. Puga A, Tomlinson C R & Xia Y, Ah receptor signals cross-talk with multiple developmental pathways, Biochem Pharmacol, 69 (2005) 199.
187. Matthews J, Wihlen B, Thomsen J & Gustafsson J A, Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters, Mol Cell Biol, 25 (2005) 5317.
188. Pillon A, Boussioux A M, Escande A, Ait-Aissa S, Gomez E, Fenet H, Ruff M, Moras D, Vignon F, Duchesne M J, Casellas C, Nicolas J C & Balaguer P, Binding of estrogenic compounds to recombinant estrogen receptor-alpha: application to environmental analysis, Environ Health Perspect, 113 (2005) 278.
189. Mimura J, Ema M, Sogawa K & Fujii-Kuriyama Y, Identification of a novel mechanism of regulation of Ah (dioxin) receptor function, Genes Dev, 13 (1998) 20.
190. Tsuchiya Y, Nakajima M, Itoh S, Iwanari M & Yokoi T, Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines, Toxicol Sci, 72 (2003) 253.
191. Denison M S & Nagy S R, Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals, Annu Rev Pharmacol Toxicol, 43 (2003) 309.
192. Amakura Y, Tsutsumi T, Sasaki K, Yoshida T & Maitani T, Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Biol Pharm Bull, 26 (2003) 1754.
193. Chen Z H, Hurh Y J, Na H K, Kim J H, Chun Y J, Kim D H, Kang K S, Cho M H & Surh Y J, Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells, Carcinogenesis, 25 (2004) 2005.
194. Jaga K & Duvvi H, Risk reduction for DDT toxicity and carcinogenesis through dietary modification, R Soc Health, 121 (2001) 107.
195. Weisburger J H, Comments on the history and importance of aromatic and heterocyclic amines in public health, Mutat Res, 506-507 (2002) 9.
196. Ray A, Cancer preventive role of selected dietary factors, Indian J Cancer, 42 (2005) 15.
197. Senft A P, Dalton T P, Nebert D W, Genter M B, Puga A, Hutchinson R J, Kerzee J K, Uno S & Shertzer H G, Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor, Free Radic Biol Med, 33 (2002) 1268.
198. Fisher M T, Nagarkatti M & Nagarkatti P S, Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Toxicol Lett, 157 (2005) 99.
199. Shen D, Dalton T P, Nebert D W & Shertzer H G, Glutathione redox state regulates mitochondrial reactive oxygen production, J Biol Chem, 280 (2005) 25305.
200. Banzet N, Francois D & Polla B S, Tobacco smoke induces mitochondrial depolarization along with cell death: effects of antioxidants, Redox Rep, 4 (1999) 229.
201. Miro O, Alonso J R, Jarreta D, Casademont J, Urbano-Marquez A & Cardellach F, Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes, Carcinogenesis, 20 (1999) 1331.
202. LeDoux S P & Wilson G L, Mitochondrial DNA: a critical target for genotoxic agents, in AACR Education Book (Am Assoc Cancer Res, Anaheim, CA) 2005, 261.
203. van Grevenynghe J, Bernard M, Langouet S, Le Berre C, Fest T & Fardel O, Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons, J Pharmacol Exp Ther, 314 (2005) 693.
204. Tuschl H & Schwab C, Cytotoxic effects of the herbicide 2,4-dichlorophenoxyacetic acid in HepG2 cells, Food Chem Toxicol, 41 (2003) 385.
205. McCarthy S, Somayajulu M, Sikorska M, Borowy-Borowski H & Pandey S, Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q 10, Toxicol Appl Pharmacol, 201 (2004) 21.
206. Delsite R, Kachhap S, Anbazhagan R, Gabrielson E & Singh K K, Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells, Mol Cancer, 1 (2002) 6.
207. Pelicano H, Carney D & Huang P, ROS stress in cancer cells and therapeutic implications, Drug Resist Updat, 7 (2004) 97.